[{"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":29999000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":153573000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2719000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":2061773.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":27453000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":83810000.0,"OtherNoncashExpense_3_Q3_USD":1492000.0,"OtherLiabilitiesCurrent_0_Q3_USD":11000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-20000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_3_Q3_USD":11033000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":7000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.092,"OperatingLeaseRightOfUseAsset_0_Q3_USD":7342000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":7079000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1023000.0,"OperatingLeaseLiability_0_Q3_USD":8102000.0,"OperatingLeaseCost_3_Q3_USD":836000.0,"OperatingLeaseCost_1_Q3_USD":339000.0,"OperatingIncomeLoss_3_Q3_USD":-46399000.0,"OperatingIncomeLoss_1_Q3_USD":-15652000.0,"OperatingExpenses_3_Q3_USD":46399000.0,"OperatingExpenses_1_Q3_USD":15652000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OtherAssetsNoncurrent_0_Q3_USD":62000.0,"NetIncomeLoss_3_Q3_USD":-47764000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":82395000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":6080000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":22212266.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":21893656.0,"VariableLeaseCost_3_Q3_USD":183000.0,"VariableLeaseCost_1_Q3_USD":65000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":1534000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":49726.0,"StockholdersEquity_0_Q3_USD":408237000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":67.15,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":78.89,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":38.11,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":55.78,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":1801838.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":78642000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":9456000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":61.28,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":172000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":2500.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":1200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":348000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":30.02,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":265843.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":6087000.0,"ShareBasedCompensation_3_Q3_USD":10174000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":4396000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-118978000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":18875000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1172450.0,"NetIncomeLoss_1_Q3_USD":-15589000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27038000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-100230000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-47784000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-15582000.0,"CommonStockValue_0_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":22237984.0,"CommonStockSharesIssued_0_Q3_shares":22237984.0,"CommonStockSharesAuthorized_0_Q3_shares":80000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":18345000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":286614000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":343100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":286614000.0,"Depreciation_1_Q3_USD":474000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":23213000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":29000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":5000.0,"AssetsCurrent_0_Q3_USD":345812000.0,"Assets_0_Q3_USD":451095000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1900638.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3745000.0,"AdditionalPaidInCapital_0_Q3_USD":527229000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-14000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3753000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1903000.0,"AccruedIncomeTaxes_0_Q3_USD":32000.0,"AccountsPayableCurrent_0_Q3_USD":4757000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":56479000.0,"Depreciation_3_Q3_USD":1400000.0,"DepreciationAndAmortization_3_Q3_USD":1985000.0,"EarningsPerShareBasic_1_Q3_USD":-0.7,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":145613000.0,"LossContingencyRelatedReceivableCarryingValueAdditions_1_Q3_USD":619000.0,"LongTermInvestments_0_Q3_USD":19237000.0,"LiabilitiesCurrent_0_Q3_USD":35779000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":451095000.0,"Liabilities_0_Q3_USD":42858000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":9444000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":255000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1114000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1135000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1162000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1094000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":17546000.0,"InterestExpense_3_Q3_USD":1492000.0,"InterestExpense_1_Q3_USD":0.0,"IncreaseDecreaseInPrepaidRent_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-814000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":6726000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-225000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":27524000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9572000.0,"GainsLossesOnSalesOfAssets_3_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3_Q3_USD":182000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q3_USD":79000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.18,"EarningsPerShareDiluted_1_Q3_USD":-0.7,"EarningsPerShareBasic_3_Q3_USD":-2.18,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":21893656.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":22212266.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]